High Accuracy of Next-Generation Flow (NGF) in Predicting Measurable Residual Disease by Next-Generation Sequencing (NGS) in the 10−6 Range: A Prospective Comparison Within the Phase III IsKia Trial
Mattia D’Agostino, Mark van Duin, Wilfried Roeloffzen, Meletios A Dimopoulos, Laura Rosiñol, Marjolein van der Klift, Roberto Mina, Albert Oriol, Eirini Katodritou, Ka Lung Wu, Paula Rodríguez‐Otero, Roman Hájek, Daniela Oddolo, Esther de Waal, Enrique M. Ocio, Mark-David Levin, María-Victoria Mateos, Paula F. Ypma, Fredrik Schjesvold, Joan Bladé, Hermann Einsele, Mario Boccadoro, Pieter Sonneveld, Annemiek Broijl, Francesca Gay (2025). High Accuracy of Next-Generation Flow (NGF) in Predicting Measurable Residual Disease by Next-Generation Sequencing (NGS) in the 10−6 Range: A Prospective Comparison Within the Phase III IsKia Trial. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)03429-9.
